| # | Drug | Count |
|---|---|---|
| 0 | CETUXIMAB | 25 |
| 1 | CISPLATIN | 21 |
| 2 | CARBOPLATIN | 20 |
| 3 | METHOTREXATE SODIUM | 20 |
| 4 | METHOTREXATE | 19 |
| 5 | LENALIDOMIDE | 17 |
| 6 | DEXAMETHASONE | 15 |
| 7 | DEXAMETHASONE 1.5 MG | 15 |
| 8 | OMEPRAZOLE MAGNESIUM | 15 |
| 9 | OMEPRAZOLE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOXYCYCLINE MONOHYDRATE | 2 | 0.0013 |
| 1 | ALDESLEUKIN | 1 | 0.0008 |
| 2 | CETUXIMAB | 25 | 0.0008 |
| 3 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 2 | 0.0007 |
| 4 | SCOPOLAMINE | 2 | 0.0005 |
| 5 | CLINDAMYCIN PHOSPHATE | 3 | 0.0005 |
| 6 | TOFACITINIB CITRATE | 5 | 0.0004 |
| 7 | TOPOTECAN | 2 | 0.0003 |
| 8 | CISPLATIN | 21 | 0.0003 |
| 9 | PROCHLORPERAZINE MALEATE | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 36 |
| 1 | Platinum-based Drug [EPC] | 36 |
| 2 | Kinase Inhibitor [EPC] | 35 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 26 |
| 4 | Microtubule Inhibitor [EPC] | 26 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 6 | Janus Kinase Inhibitor [EPC] | 18 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 8 | Thalidomide Analog [EPC] | 17 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 26 | 0.0005 |
| 3 | RNA Synthetase Inhibitor Antibacterial [EPC] | 3 | 0.0002 |
| 4 | Microtubule Inhibitor [EPC] | 26 | 0.0002 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 36 | 0.0001 |
| 8 | Anticholinergic [EPC] | 2 | 0.0001 |
| 9 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |